MQS Management LLC Invests $1.05 Million in Colgate-Palmolive (NYSE:CL)

MQS Management LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 10,157 shares of the company's stock, valued at approximately $1,054,000. Colgate-Palmolive accounts for approximately 0.6% of MQS Management LLC's portfolio, making the stock its 12th largest position.

Other institutional investors also recently bought and sold shares of the company. TD Asset Management Inc lifted its position in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock worth $103,969,000 after buying an additional 26,987 shares during the period. M&G Plc purchased a new position in Colgate-Palmolive during the first quarter worth about $3,812,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive during the third quarter worth about $602,000. Vontobel Holding Ltd. increased its stake in Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company's stock worth $82,626,000 after acquiring an additional 550,750 shares during the last quarter. Finally, PGGM Investments increased its stake in Colgate-Palmolive by 171.8% during the second quarter. PGGM Investments now owns 157,608 shares of the company's stock worth $15,294,000 after acquiring an additional 99,624 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CL shares. TD Cowen lowered their target price on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Sanford C. Bernstein increased their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a research note on Thursday, August 1st. UBS Group raised their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Finally, Hsbc Global Res lowered Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 26th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded down $0.43 during trading on Wednesday, reaching $91.07. The company's stock had a trading volume of 3,441,368 shares, compared to its average volume of 4,372,932. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The business's fifty day moving average price is $100.30 and its 200-day moving average price is $98.53. The firm has a market cap of $74.41 billion, a price-to-earnings ratio of 26.13, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.